Title : Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression.

Pub. Date : 2008 Mar

PMID : 18084316






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Celecoxib modulates adhesion of HT29 colon cancer cells to vascular endothelial cells by inhibiting ICAM-1 and VCAM-1 expression. Celecoxib vascular cell adhesion molecule 1 Homo sapiens
2 Recently, the selective COX-2 inhibitor, celecoxib, was shown to inhibit expression of the adhesion molecules, ICAM-1 and VCAM-1, in the human colon cancer cell line HT29 and to inhibit adhesion of HT29 cells to FCS-coated plastic wells. Celecoxib vascular cell adhesion molecule 1 Homo sapiens
3 Analysis of ICAM-1 and VCAM-1 expression showed that celecoxib inhibited expression of both molecules in TNF-alpha-stimulated HUVEC, but not in resting HUVEC; inhibition was concentration-dependent and maximal (about 50%) at 10 microM celecoxib. Celecoxib vascular cell adhesion molecule 1 Homo sapiens
4 CONCLUSIONS AND IMPLICATIONS: In conclusion, our data show that celecoxib inhibits HT29 cell adhesion to HUVEC and expression of ICAM-1 and VCAM-1, in stimulated endothelial cells. Celecoxib vascular cell adhesion molecule 1 Homo sapiens